Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir

No abstract is available for this paper.

• Publication year

  2006

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/aid.2006.22.333PMID 16623636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-Induced Hyperglycemia and Diabetes Mellitus

  2016cited by this paper
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

  2007cited by this paper
• Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

  2007cited by this paper
• Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127

  2006cited by this paper
• Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine

  2005cited by this paper
• An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine.

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

  2005cited by this paper
• Diagnosis and classification of diabetes mellitus.

  2004cited by this paper
• Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.

  2004cited by this paper
• Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

  2004cited by this paper
• Combinations of nucleoside/nucleotide analogues for HIV therapy.

  2004cited by this paper
• Triple-nucleoside regimens versus efavirenz.

  2004cited by this paper
• Tenofovir-related nephrotoxicity in HIV-infected patients.

  2004cited by this paper
• Vascular higher-level gait disorders--a step in the right direction?

  2004cited by this paper
• An objective case definition of lipodystrophy in HIV-infected adults: a case-control study.

  2003cited by this paper
• The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy*

  2000influential reference
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS).

  1997cited by this paper
• Transient insulin-dependent diabetes mellitus in an HIV-infected patient receiving didanosine.

  1994cited by this paper
• Hyperosmolar Nonketotic Diabetic Syndrome Following Treatment of Human Immunodeficiency Virus Infection With Didanosine

  1994cited by this paper
• The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)

  1993cited by this paper
• Didanosine-induced Disorders of Glucose Tolerance

  1993cited by this paper
• Didanosine and ACTG 116A

  1993cited by this paper
• Didanosine-induced disorders of glucose tolerance.

  1993cited by this paper
• Didanosine and ACTG 116A.

  1993cited by this paper

• Anti-HIV Drugs Reduce Risk of Prediabetes and Progression to Type 2 Diabetes in HIV-Infected Patients.

  2023cites this paper
• Tenofovir-silver nanoparticles conjugate ameliorates neurocognitive disorders and protects ultrastructural and cytoarchitectonic properties of the prefrontal cortex in diabetic rats

  2022cites this paper
• Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study

  2021cites this paper
• Metabolic abnormalities among HIV-infected patients: The rational of national health security for people living with HIV

  2020cites this paper
• Diabetes mellitus burden among people living with HIV from the Asia‐Pacific region

  2019cites this paper
• Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy: A Systematic Review and Meta-analysis

  2018cites this paper
• Drug-Induced Hyperglycemia and Diabetes Mellitus

  2016cites this paper
• Type 2 Diabetes: Geriatric Considerations

  2016cites this paper
• Pharmacokinetic herb-drug interaction study of selected traditional medicines used as complementary and alternative medicine (CAM) for HIV/AIDS

  2015cites this paper
• New-Onset Diabetes Mellitus With Exposure to Ledipasvir and Sofosbuvir

  2015cites this paper
• Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

  2012cites this paper
• Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

  2012cites this paper
• Critical appraisal and update on tenofovir in management of human immunodeficiency virus infection

  2011cites this paper
• Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients

  2011cites this paper
• Renal toxicity associated with tenofovir use

  2010cites this paper
• HIV Infection and Diabetes

  2010cites this paper
• Glucose disorders associated with antiretroviral therapy: an overview.

  2009cites this paper
• Chapter 29 - Antiviral drugs

  2009cites this paper
• Effect of HCV Infection on Glucose Metabolism in Pregnant Women with HIV Receiving HAART

  2009cites this paper
• Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

  2008cites this paper
• Update on the treatment of chronic hepatitis C in HIV-infected patients.

  2007cites this paper
• Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

  2007cites this paper
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

  2007cites this paper
• Reviewer No.1 check list for application for addition: Tenofovir Disoproxil Fumarate (TDF)

  2006cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2006cites this paper
• Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127

  2006cites this paper